Survival Time among Young and Old Breast Cancer Patients in Relation to Circulating Blood-Based Biomarkers, Acute Radiation Skin Reactions, and Tumour Recurrence
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Survival Time among Young and Old Breast Cancer Patients in Relation to Circulating Blood-Based Biomarkers, Acute Radiation Skin Reactions, and Tumour Recurrence ; volume:99 ; number:11 ; year:2021 ; pages:740-746 ; extent:7
Oncology ; 99, Heft 11 (2021), 740-746 (gesamt 7)
- Creator
-
Laytragoon Lewin, Nongnit
Oliva, Delmy
Nilsson, Mats
Andersson, Bengt-Åke
Löfgren, Sture
Lewin, Freddi
- DOI
-
10.1159/000518184
- URN
-
urn:nbn:de:101:1-2021111023314455799733
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Laytragoon Lewin, Nongnit
- Oliva, Delmy
- Nilsson, Mats
- Andersson, Bengt-Åke
- Löfgren, Sture
- Lewin, Freddi
Other Objects (12)
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancer
Biomarkers in cancer/Circulating tumour markers
Liquid biopsy: blood‐based analyses of circulating cell‐free DNA in xenografts
Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer
Circulating Tumour DNA in Melanoma—Clinic Ready?
Dynamically monitoring minimal residual disease using circulating tumour cells to predict the recurrence of early-stage lung adenocarcinoma
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Ex vivo expansion of circulating tumour cells (CTCs)
Unravelling mutational signatures with plasma circulating tumour DNA
Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancer
Biomarkers in cancer/Circulating tumour markers
Liquid biopsy: blood‐based analyses of circulating cell‐free DNA in xenografts
Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer
Circulating Tumour DNA in Melanoma—Clinic Ready?
Dynamically monitoring minimal residual disease using circulating tumour cells to predict the recurrence of early-stage lung adenocarcinoma
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Ex vivo expansion of circulating tumour cells (CTCs)
Unravelling mutational signatures with plasma circulating tumour DNA
Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancer
Biomarkers in cancer/Circulating tumour markers
Liquid biopsy: blood‐based analyses of circulating cell‐free DNA in xenografts
Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer
Circulating Tumour DNA in Melanoma—Clinic Ready?
Dynamically monitoring minimal residual disease using circulating tumour cells to predict the recurrence of early-stage lung adenocarcinoma
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Ex vivo expansion of circulating tumour cells (CTCs)
Unravelling mutational signatures with plasma circulating tumour DNA